Global Kaposi Sarcoma Market: High Cost of Treatment to Slow Down Growth
The global Kaposi sarcoma (KS) market is consolidated with the top two players accounting for a whopping 50% of the market in 2015. These two players are Johnson & Johnson and Merck & Co. Inc. Domestic players are unable to make much contribution to the growth of the KS market. However, this trend is soon to change, says a new report by Transparency Market Research. As per the research report, companies will be able to make more contribution after the...
View full press release